Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. LaFave, L.M. et al. Nat. Med. 21, 1344–1349 (2015).

    Article  CAS  Google Scholar 

  2. Schoumacher, M. et al. Nat. Med. 22, 577–578 (2016).

    Article  CAS  Google Scholar 

  3. Kim, K.H. & Roberts, C.W. Nat. Med. 22, 128–134 (2016).

    Article  CAS  Google Scholar 

  4. Fong, C.Y. et al. Nature 525, 538–542 (2015).

    Article  CAS  Google Scholar 

  5. Matatall, K.A. et al. BMC Cancer 13, 371 (2013).

    Article  Google Scholar 

  6. Harbour, J.W. et al. Science 330, 1410–1413 (2010).

    Article  CAS  Google Scholar 

  7. Campbell, J.E. et al. ACS Med. Chem. Lett. 6, 491–495 (2015).

    Article  CAS  Google Scholar 

  8. Kim, K.H. et al. Nat. Med. 21, 1491–1496 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ross L Levine.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

LaFave, L., Béguelin, W., Koche, R. et al. Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status". Nat Med 22, 578–579 (2016). https://doi.org/10.1038/nm.4094

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.4094

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer